A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

BACKGROUND: Dolutegravir (DTG) plus darunavir/ritonavir (DRV/r) is a simple combination of drugs that has the best genetic barrier to HIV-1 resistance and may be fit for salvage therapy. METHODS: All HIV-1-infected subjects treated with DTG plus DRV/r between March 2014 and September 2015 in eight I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Capetti, Amedeo F., Cossu, Maria Vittoria, Orofino, Giancarlo, Sterrantino, Gaetana, Cenderello, Giovanni, De Socio, Giuseppe V., Cattelan, Anna Maria, Soria, Alessandro, Rusconi, Stefano, Riccardi, Niccolò, Baldin, Gian Maria, Niero, Fosca P., Barbarini, Giorgio, Rizzardini, Giuliano
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5622573/
https://ncbi.nlm.nih.gov/pubmed/28964268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2755-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados